{"id":893171,"date":"2025-10-07T08:25:18","date_gmt":"2025-10-07T12:25:18","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\/"},"modified":"2025-10-07T08:25:18","modified_gmt":"2025-10-07T12:25:18","slug":"genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\/","title":{"rendered":"GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025"},"content":{"rendered":"

<\/p>\n

GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025<\/b><\/p>\n

GAITHERSBURG, Md.–(BUSINESS WIRE<\/a>)–
\nGeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will release financial results for the third quarter of 2025 before the market opens on Tuesday, October 28, 2025. Management will host a conference call that day to discuss third quarter 2025 financial and operating results at 8:30 a.m. Eastern Time.<\/p>\n

\nConference Call Details<\/p>\n

\nInvestors interested in listening to the conference call are required to register online. A live and archived webcast of the event will be available on the \u201cEvents\u201d section of the GeneDx investor relations website at https:\/\/ir.genedx.com\/<\/a>.<\/p>\n

About GeneDx<\/b><\/p>\n

\nGeneDx (Nasdaq: WGS) is the global leader in rare disease diagnosis, transforming the way medicine is practiced by making genomics the starting point for health, not the last resort. We bring together unmatched clinical expertise, advanced technology, and the power of GeneDx Infinity\u2122 \u2013 the largest rare disease dataset \u2013 built over 25 years from millions of genomic tests and deep clinical insights. This unparalleled foundation powers our ExomeDx and GenomeDx tests, giving clinicians the highest likelihood of delivering a timely, accurate diagnosis. GeneDx is shaping the future of healthcare by moving the standard of care from sick care to proactive healthcare. While our roots are in rare disease diagnosis, our commitment extends beyond \u2013 growing with the families we serve \u2013 as a trusted partner at every stage of life. For more information, visit genedx.com<\/a> and connect with us on LinkedIn<\/a>, Facebook<\/a>, and Instagram<\/a>.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20251007837117\/en\/<\/a><\/span><\/p>\n

Investor Relations Contact:
\n<\/b>
Investors@GeneDx.com<\/a><\/p>\n

Media Contact:
\n<\/b>
Press@GeneDx.com<\/a><\/p>\n

KEYWORDS:<\/b> United States North America Maryland<\/p>\n

INDUSTRY KEYWORDS:<\/b> Biotechnology Medical Devices Health Genetics Clinical Trials<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025 GAITHERSBURG, Md.–(BUSINESS WIRE)– GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will release financial results for the third quarter of 2025 before the market opens on Tuesday, October 28, 2025. Management will host a conference call that day to discuss third quarter 2025 financial and operating results at 8:30 a.m. Eastern Time. Conference Call Details Investors interested in listening to the conference call are required to register online. A live and archived webcast of the event will be available on the \u201cEvents\u201d section of the GeneDx investor relations website at https:\/\/ir.genedx.com\/. About GeneDx GeneDx (Nasdaq: WGS) is the global … <\/p>\n

Continue reading “GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-893171","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nGeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025 GAITHERSBURG, Md.–(BUSINESS WIRE)– GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will release financial results for the third quarter of 2025 before the market opens on Tuesday, October 28, 2025. Management will host a conference call that day to discuss third quarter 2025 financial and operating results at 8:30 a.m. Eastern Time. Conference Call Details Investors interested in listening to the conference call are required to register online. A live and archived webcast of the event will be available on the \u201cEvents\u201d section of the GeneDx investor relations website at https:\/\/ir.genedx.com\/. About GeneDx GeneDx (Nasdaq: WGS) is the global … Continue reading "GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-07T12:25:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251007837117r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025\",\"datePublished\":\"2025-10-07T12:25:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\\\/\"},\"wordCount\":305,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251007837117r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\\\/\",\"name\":\"GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251007837117r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2025-10-07T12:25:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251007837117r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20251007837117r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\/","og_locale":"en_US","og_type":"article","og_title":"GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025 - Market Newsdesk","og_description":"GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025 GAITHERSBURG, Md.–(BUSINESS WIRE)– GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it will release financial results for the third quarter of 2025 before the market opens on Tuesday, October 28, 2025. Management will host a conference call that day to discuss third quarter 2025 financial and operating results at 8:30 a.m. Eastern Time. Conference Call Details Investors interested in listening to the conference call are required to register online. A live and archived webcast of the event will be available on the \u201cEvents\u201d section of the GeneDx investor relations website at https:\/\/ir.genedx.com\/. About GeneDx GeneDx (Nasdaq: WGS) is the global … Continue reading \"GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-10-07T12:25:18+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251007837117r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025","datePublished":"2025-10-07T12:25:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\/"},"wordCount":305,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251007837117r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\/","name":"GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251007837117r1&sid=flmnd&distro=nx&lang=en","datePublished":"2025-10-07T12:25:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251007837117r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20251007837117r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/genedx-to-report-third-quarter-2025-financial-results-on-tuesday-october-28-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/893171","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=893171"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/893171\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=893171"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=893171"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=893171"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}